What Is the moral responsibility of health care providers to report HBV or HCV status if they perform invasive procedures?
Jessica L. Mellinger – 28 October 2015 – Watch a video presentation of this article
Management of patients with hepatitis C virus resistance–associated variants to NS5A inhibitors: Where are we now?
Jennifer T. Wells, Carmen Landaverde, Julio Gutierrez, Eric Lawitz – 28 October 2015 – Watch a video presentation of this article
Criteria for liver transplantation in hepatocellular carcinoma
Laura Kulik – 28 October 2015 – Watch a video presentation of this article
Transplant tourism versus proper travel for transplantation
John S. Gill, Francis L. Delmonico – 28 October 2015 – Watch a video presentation of this article
The DNAJB1‐PRKACA chimera: Candidate biomarker and therapeutic target for fibrolamellar carcinomas
Lola M. Reid, Praveen Sethupathy – 27 October 2015
Liver capsule: Entry and entry inhibition of hepatitis B virus and hepatitis delta virus into hepatocytes
Stephan Urban – 26 October 2015
Excellent outcomes of liver transplantation using severely steatotic grafts from brain‐dead donors
Francesco Tandoi, Mauro Salizzoni, Andrea Brunati, Francesco Lupo, Renato Romagnoli – 22 October 2015
Reply
Vincent Wai‐Sun Wong, Grace Lai‐Hung Wong, Henry Lik‐Yuen Chan – 21 October 2015
Nonalcoholic fatty liver disease, cardiovascular outcomes, and mortality in patients undergoing a coronary angiogram
Giovanni Targher, Christopher D. Byrne – 21 October 2015
Costs and consequences: Hepatitis C seroprevalence in the military and its impact on potential screening strategies
David M. Brett‐Major, Kevin D. Frick, Jennifer A. Malia, Shilpa Hakre, Jason F. Okulicz, Charmagne G. Beckett, Linda L. Jagodinski, Michael A. Forgione, Philip L. Gould, Stephen A. Harrison, Clinton K. Murray, Francisco J. Rentas, Adam W. Armstrong, Aatif M. Hayat, Laura A. Pacha, Peter Dawson, Angelia A. Eick‐Cost, Hala H. Maktabi, Nelson L. Michael, Steven B. Cersovsky, Sheila A. Peel, Paul T. Scott – 20 October 2015 – Knowledge of the contemporary epidemiology of hepatitis C viral (HCV) infection among military personnel can inform potential Department of Defense screening policy.